Deepinder Goyal’s Temple shrinks wearable for limited preorder launch

Brain-monitoring wearable Temple has been redesigned to less than half the size of its original version. The company plans to open preorders for a limited first batch, with 100 selected users set to test the device and shipments targeted before the end of 2026.

— Source published Fri, 21 Aug, 2026, 16:09 IST · First seen Fri, 21 Aug, 2026, 16:27 IST · Source Business Today · Latest

What happened

Deepinder Goyal’s brain-monitoring wearable Temple has been redesigned to less than half its original size. A limited launch edition will open for preorder

Key facts

  • less than half the size of the original version
  • first 100 devices
  • shipping before end-2026

Why this matters

Temple’s brain-monitoring positioning and high-profile founder create a potential partnership target for health-tech, wellness and wearable platforms seeking differentiated neurotechnology.

What to watch

  • Actual preorder price, deposit structure, geographic availability and the size of the first batch beyond the 100-user test group.
  • Battery-life claims, wear duration, sensor placement and whether the reduced size changes the device’s visible form factor.
  • Disclosure of the first supported use case and whether Temple makes medical, wellness or productivity claims.
  • Pilot-user retention after 30, 60 and 90 days, especially daily active usage versus novelty-driven trial.
  • Evidence of signal accuracy or independent validation compared with incumbent EEG and wellness wearables.
  • Privacy policy details, regulatory classification and any requirement for health-data compliance.
  • Manufacturing partner announcements, shipment-date specificity and signs of supply-chain readiness before end-2026.
  • Whether Temple introduces a subscription, coaching layer or enterprise/research offering alongside hardware.
  • Use the 100-user cohort as a tightly managed evidence program, measuring daily wear time, comfort, signal reliability, battery performance, retention and willingness to pay.
  • Clarify the initial consumer promise around one or two high-frequency use cases—such as focus, stress, sleep or meditation—rather than broad brain monitoring.
  • Publish a transparent privacy architecture covering data ownership, consent, storage, model training and whether neurological data is shared with partners.
  • Build scarcity-led preorder mechanics with refundable deposits or invite tiers, while avoiding volume commitments before pilot performance is proven.
  • Secure clinical, research or wellness partnerships that can validate outcomes and create credibility beyond founder-led attention.
  • Design an accessory and replacement strategy for charging, fit components and upgrades, since ongoing wearability will determine repeat revenue and support costs.